e-Algerian Journal of Health & Research
Volume 2, Numéro 1, Pages 110-113
2025-12-18

Treatment Of Relapsed Early T-cell Precursor Acute Lymphoblastic Leukemia With Venetoclax.

Authors : Hadjeb Asma . Si Ali Nadjat . Tayebi Karima . Chereti Malika . Ramdoum Amina . Benlazar Mohamed .

Abstract

Early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) is a biologically distinct entity in the 2022 WHO classification and is associated with a poor prognosis due to its resistance to chemotherapy and high relapse rate. Targeting oncogenic proteins of the BCL-2 family with agents such as Venetoclax offers a therapeutic alternative for patients with refractory or relapsed disease. In this case report, we describe a patient with relapsed disease refractory to standard treatment, who was managed with a short course of Venetoclax.

Keywords

Early T-cell precursor acute lymphoblastic leukemia , ETP-ALL, Venetoclax.

Prognostic Impact Of Genetic Abnormalities In Acute Myeloid Leukemia: A Retrospective Study At The University Hospital Of Oran

Cherif Hosni Aicha .  Kehal Samia .  Meghrebi Sara .  Lahmer Imene .  Messaoudi Reda . 
pages 452-459.


Frequency Of Bcr-abl 1 Fusion Transcripts Variants In Chronic Myeloid Leukemia Algerian Patients

Nachi Mourad .  Kihek Ibtissem .  Entasoltan Badra .  Taibi Karima .  Guella Mohamed Djaoued .  Abed Amine .  Boukhatmi Yasmine .  Bekadja Mohamed Amine . 
pages 527-532.